instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Restlessness'? | Possible inhibitory effects of terbinafine on aripiprazole metabolism: Two case reports.
Aripiprazole, an atypical antipsychotic, is a metabolic substrate for cytochrome P450 (CYP)3A4 and 2D6. Terbinafine, an antifungal agent used for onychomycosis, is a CYP2D6 inhibitor and could theoretically reduce the metabolism of... | Not recovered | ReactionOutcome | CC BY-NC | 34621606 | 19,999,904 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Treatment of bilateral granulomatous lobular mastitis during lactation with traditional Chinese medicine: A case report.
BACKGROUND
Granulomatous lobular mastitis (GLM) is a type of benign chronic inflammatory disease that poses therapeutic challenges to healthcare providers. The diagnosis of GLM relies on tissue biops... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, RIFAMPIN | DrugsGivenReaction | CC BY-NC | 34621888 | 20,448,117 | 2021-09-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during breast feeding'. | Treatment of bilateral granulomatous lobular mastitis during lactation with traditional Chinese medicine: A case report.
BACKGROUND
Granulomatous lobular mastitis (GLM) is a type of benign chronic inflammatory disease that poses therapeutic challenges to healthcare providers. The diagnosis of GLM relies on tissue biops... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, RIFAMPIN | DrugsGivenReaction | CC BY-NC | 34621888 | 20,448,117 | 2021-09-26 |
What was the administration route of drug 'ETHAMBUTOL HYDROCHLORIDE'? | Treatment of bilateral granulomatous lobular mastitis during lactation with traditional Chinese medicine: A case report.
BACKGROUND
Granulomatous lobular mastitis (GLM) is a type of benign chronic inflammatory disease that poses therapeutic challenges to healthcare providers. The diagnosis of GLM relies on tissue biops... | Oral | DrugAdministrationRoute | CC BY-NC | 34621888 | 20,448,117 | 2021-09-26 |
What was the administration route of drug 'ISONIAZID'? | Treatment of bilateral granulomatous lobular mastitis during lactation with traditional Chinese medicine: A case report.
BACKGROUND
Granulomatous lobular mastitis (GLM) is a type of benign chronic inflammatory disease that poses therapeutic challenges to healthcare providers. The diagnosis of GLM relies on tissue biops... | Oral | DrugAdministrationRoute | CC BY-NC | 34621888 | 20,448,117 | 2021-09-26 |
What was the administration route of drug 'RIFAMPIN'? | Treatment of bilateral granulomatous lobular mastitis during lactation with traditional Chinese medicine: A case report.
BACKGROUND
Granulomatous lobular mastitis (GLM) is a type of benign chronic inflammatory disease that poses therapeutic challenges to healthcare providers. The diagnosis of GLM relies on tissue biops... | Oral | DrugAdministrationRoute | CC BY-NC | 34621888 | 20,448,117 | 2021-09-26 |
What was the dosage of drug 'ETHAMBUTOL HYDROCHLORIDE'? | Treatment of bilateral granulomatous lobular mastitis during lactation with traditional Chinese medicine: A case report.
BACKGROUND
Granulomatous lobular mastitis (GLM) is a type of benign chronic inflammatory disease that poses therapeutic challenges to healthcare providers. The diagnosis of GLM relies on tissue biops... | UNK, QD | DrugDosageText | CC BY-NC | 34621888 | 20,448,117 | 2021-09-26 |
What was the dosage of drug 'ISONIAZID'? | Treatment of bilateral granulomatous lobular mastitis during lactation with traditional Chinese medicine: A case report.
BACKGROUND
Granulomatous lobular mastitis (GLM) is a type of benign chronic inflammatory disease that poses therapeutic challenges to healthcare providers. The diagnosis of GLM relies on tissue biops... | UNK, QD | DrugDosageText | CC BY-NC | 34621888 | 20,448,117 | 2021-09-26 |
What was the dosage of drug 'RIFAMPIN'? | Treatment of bilateral granulomatous lobular mastitis during lactation with traditional Chinese medicine: A case report.
BACKGROUND
Granulomatous lobular mastitis (GLM) is a type of benign chronic inflammatory disease that poses therapeutic challenges to healthcare providers. The diagnosis of GLM relies on tissue biops... | UNK UNK, QD | DrugDosageText | CC BY-NC | 34621888 | 20,448,117 | 2021-09-26 |
What was the administration route of drug 'PANTOPRAZOLE'? | A Case of Lansoprazole-Induced Bullous Pemphigoid After Zantac Recall.
Proton pump inhibitors (PPIs) are the mainstay of treatment for many gastric acid-related diseases with a relatively safe drug profile. One of the rare side effects is PPI-induced bullous pemphigoid. We describe a case of new-onset bullous pemphigoi... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34621909 | 19,975,337 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | Idiopathic intracranial hypertension in a pediatric transgender patient.
Androgens given for gender affirmation have been implicated in the pathophysiology of idiopathic intracranial hypertension (IIH) in transgender patients. 10 cases of transgender adults with IIH have been published but this association has not been... | TESTOSTERONE | DrugsGivenReaction | CC BY-NC-ND | 34622090 | 20,439,855 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Idiopathic intracranial hypertension'. | Idiopathic intracranial hypertension in a pediatric transgender patient.
Androgens given for gender affirmation have been implicated in the pathophysiology of idiopathic intracranial hypertension (IIH) in transgender patients. 10 cases of transgender adults with IIH have been published but this association has not been... | TESTOSTERONE | DrugsGivenReaction | CC BY-NC-ND | 34622090 | 20,453,864 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Idiopathic intracranial hypertension in a pediatric transgender patient.
Androgens given for gender affirmation have been implicated in the pathophysiology of idiopathic intracranial hypertension (IIH) in transgender patients. 10 cases of transgender adults with IIH have been published but this association has not been... | TESTOSTERONE | DrugsGivenReaction | CC BY-NC-ND | 34622090 | 20,437,528 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Papilloedema'. | Idiopathic intracranial hypertension in a pediatric transgender patient.
Androgens given for gender affirmation have been implicated in the pathophysiology of idiopathic intracranial hypertension (IIH) in transgender patients. 10 cases of transgender adults with IIH have been published but this association has not been... | TESTOSTERONE | DrugsGivenReaction | CC BY-NC-ND | 34622090 | 20,437,528 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Visual impairment'. | Idiopathic intracranial hypertension in a pediatric transgender patient.
Androgens given for gender affirmation have been implicated in the pathophysiology of idiopathic intracranial hypertension (IIH) in transgender patients. 10 cases of transgender adults with IIH have been published but this association has not been... | TESTOSTERONE | DrugsGivenReaction | CC BY-NC-ND | 34622090 | 20,439,855 | 2021-12 |
What was the administration route of drug 'TESTOSTERONE'? | Idiopathic intracranial hypertension in a pediatric transgender patient.
Androgens given for gender affirmation have been implicated in the pathophysiology of idiopathic intracranial hypertension (IIH) in transgender patients. 10 cases of transgender adults with IIH have been published but this association has not been... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 34622090 | 20,453,864 | 2021-12 |
What was the outcome of reaction 'Headache'? | Idiopathic intracranial hypertension in a pediatric transgender patient.
Androgens given for gender affirmation have been implicated in the pathophysiology of idiopathic intracranial hypertension (IIH) in transgender patients. 10 cases of transgender adults with IIH have been published but this association has not been... | Recovered | ReactionOutcome | CC BY-NC-ND | 34622090 | 20,439,855 | 2021-12 |
What was the outcome of reaction 'Idiopathic intracranial hypertension'? | Idiopathic intracranial hypertension in a pediatric transgender patient.
Androgens given for gender affirmation have been implicated in the pathophysiology of idiopathic intracranial hypertension (IIH) in transgender patients. 10 cases of transgender adults with IIH have been published but this association has not been... | Recovered | ReactionOutcome | CC BY-NC-ND | 34622090 | 20,453,864 | 2021-12 |
What was the outcome of reaction 'Papilloedema'? | Idiopathic intracranial hypertension in a pediatric transgender patient.
Androgens given for gender affirmation have been implicated in the pathophysiology of idiopathic intracranial hypertension (IIH) in transgender patients. 10 cases of transgender adults with IIH have been published but this association has not been... | Recovered | ReactionOutcome | CC BY-NC-ND | 34622090 | 20,437,528 | 2021-12 |
What was the outcome of reaction 'Visual impairment'? | Idiopathic intracranial hypertension in a pediatric transgender patient.
Androgens given for gender affirmation have been implicated in the pathophysiology of idiopathic intracranial hypertension (IIH) in transgender patients. 10 cases of transgender adults with IIH have been published but this association has not been... | Recovered | ReactionOutcome | CC BY-NC-ND | 34622090 | 20,439,855 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case report.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare disease due to small vessel inflammation and characterized by chronic urticaria... | AZATHIOPRINE, MYCOPHENOLATE MOFETIL, PREDNISONE | DrugsGivenReaction | CC BY-NC | 34622135 | 20,044,127 | 2021-09 |
What was the outcome of reaction 'Brain oedema'? | Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case report.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare disease due to small vessel inflammation and characterized by chronic urticaria... | Fatal | ReactionOutcome | CC BY-NC | 34622135 | 20,057,042 | 2021-09 |
What was the outcome of reaction 'Cerebral artery embolism'? | Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case report.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare disease due to small vessel inflammation and characterized by chronic urticaria... | Fatal | ReactionOutcome | CC BY-NC | 34622135 | 20,057,042 | 2021-09 |
What was the outcome of reaction 'Cerebral haemorrhage'? | Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case report.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare disease due to small vessel inflammation and characterized by chronic urticaria... | Fatal | ReactionOutcome | CC BY-NC | 34622135 | 20,057,042 | 2021-09 |
What was the outcome of reaction 'Condition aggravated'? | Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case report.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare disease due to small vessel inflammation and characterized by chronic urticaria... | Fatal | ReactionOutcome | CC BY-NC | 34622135 | 20,057,042 | 2021-09 |
What was the outcome of reaction 'Coronary artery embolism'? | Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case report.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare disease due to small vessel inflammation and characterized by chronic urticaria... | Fatal | ReactionOutcome | CC BY-NC | 34622135 | 20,057,042 | 2021-09 |
What was the outcome of reaction 'Endocarditis'? | Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case report.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare disease due to small vessel inflammation and characterized by chronic urticaria... | Fatal | ReactionOutcome | CC BY-NC | 34622135 | 20,057,042 | 2021-09 |
What was the outcome of reaction 'Infective aneurysm'? | Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case report.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare disease due to small vessel inflammation and characterized by chronic urticaria... | Fatal | ReactionOutcome | CC BY-NC | 34622135 | 20,057,042 | 2021-09 |
What was the outcome of reaction 'Infective aortitis'? | Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case report.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare disease due to small vessel inflammation and characterized by chronic urticaria... | Fatal | ReactionOutcome | CC BY-NC | 34622135 | 20,057,042 | 2021-09 |
What was the outcome of reaction 'Listeriosis'? | Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case report.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare disease due to small vessel inflammation and characterized by chronic urticaria... | Fatal | ReactionOutcome | CC BY-NC | 34622135 | 20,057,042 | 2021-09 |
What was the outcome of reaction 'Pyelonephritis'? | Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case report.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare disease due to small vessel inflammation and characterized by chronic urticaria... | Fatal | ReactionOutcome | CC BY-NC | 34622135 | 20,057,042 | 2021-09 |
What was the outcome of reaction 'Septic embolus'? | Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case report.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare disease due to small vessel inflammation and characterized by chronic urticaria... | Fatal | ReactionOutcome | CC BY-NC | 34622135 | 20,057,042 | 2021-09 |
What was the outcome of reaction 'Systemic infection'? | Heart valve disease in hypocomplementemic urticarial vasculitis syndrome: from immune-mediated degeneration to embolic complications of infective endocarditis-a case report.
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare disease due to small vessel inflammation and characterized by chronic urticaria... | Fatal | ReactionOutcome | CC BY-NC | 34622135 | 20,057,042 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Drug-resistant high grade glioma-related epilepsy surgery for focal motor status epilepticus localized by CT-PET imaging.
Tumor-related epilepsy is a frequent complication of glioblastoma with seizures often representing the first manifestation of the malignancy. Though tumor resection is associated with improved seizu... | CLOBAZAM, DIVALPROEX SODIUM, LACOSAMIDE, LEVETIRACETAM, LORAZEPAM, TEMOZOLOMIDE, TOPIRAMATE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34622193 | 20,435,659 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoaesthesia'. | Drug-resistant high grade glioma-related epilepsy surgery for focal motor status epilepticus localized by CT-PET imaging.
Tumor-related epilepsy is a frequent complication of glioblastoma with seizures often representing the first manifestation of the malignancy. Though tumor resection is associated with improved seizu... | CLOBAZAM, DIVALPROEX SODIUM, LACOSAMIDE, LEVETIRACETAM, LORAZEPAM, TEMOZOLOMIDE, TOPIRAMATE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34622193 | 20,435,659 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Language disorder'. | Drug-resistant high grade glioma-related epilepsy surgery for focal motor status epilepticus localized by CT-PET imaging.
Tumor-related epilepsy is a frequent complication of glioblastoma with seizures often representing the first manifestation of the malignancy. Though tumor resection is associated with improved seizu... | CLOBAZAM, DIVALPROEX SODIUM, LACOSAMIDE, LEVETIRACETAM, LORAZEPAM, TEMOZOLOMIDE, TOPIRAMATE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34622193 | 20,435,659 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lethargy'. | Drug-resistant high grade glioma-related epilepsy surgery for focal motor status epilepticus localized by CT-PET imaging.
Tumor-related epilepsy is a frequent complication of glioblastoma with seizures often representing the first manifestation of the malignancy. Though tumor resection is associated with improved seizu... | CLOBAZAM, DIVALPROEX SODIUM, LACOSAMIDE, LEVETIRACETAM, LORAZEPAM, TEMOZOLOMIDE, TOPIRAMATE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34622193 | 20,435,659 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple-drug resistance'. | Drug-resistant high grade glioma-related epilepsy surgery for focal motor status epilepticus localized by CT-PET imaging.
Tumor-related epilepsy is a frequent complication of glioblastoma with seizures often representing the first manifestation of the malignancy. Though tumor resection is associated with improved seizu... | CLOBAZAM, LACOSAMIDE, LEVETIRACETAM, LORAZEPAM, TEMOZOLOMIDE, TOPIRAMATE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34622193 | 20,432,289 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Status epilepticus'. | Drug-resistant high grade glioma-related epilepsy surgery for focal motor status epilepticus localized by CT-PET imaging.
Tumor-related epilepsy is a frequent complication of glioblastoma with seizures often representing the first manifestation of the malignancy. Though tumor resection is associated with improved seizu... | CLOBAZAM, LACOSAMIDE, LEVETIRACETAM, LORAZEPAM, TEMOZOLOMIDE, TOPIRAMATE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-ND | 34622193 | 20,432,289 | 2021 |
What was the outcome of reaction 'Language disorder'? | Drug-resistant high grade glioma-related epilepsy surgery for focal motor status epilepticus localized by CT-PET imaging.
Tumor-related epilepsy is a frequent complication of glioblastoma with seizures often representing the first manifestation of the malignancy. Though tumor resection is associated with improved seizu... | Recovering | ReactionOutcome | CC BY-NC-ND | 34622193 | 20,435,659 | 2021 |
What was the outcome of reaction 'Somnolence'? | Drug-resistant high grade glioma-related epilepsy surgery for focal motor status epilepticus localized by CT-PET imaging.
Tumor-related epilepsy is a frequent complication of glioblastoma with seizures often representing the first manifestation of the malignancy. Though tumor resection is associated with improved seizu... | Recovering | ReactionOutcome | CC BY-NC-ND | 34622193 | 20,435,659 | 2021 |
What was the outcome of reaction 'Status epilepticus'? | Drug-resistant high grade glioma-related epilepsy surgery for focal motor status epilepticus localized by CT-PET imaging.
Tumor-related epilepsy is a frequent complication of glioblastoma with seizures often representing the first manifestation of the malignancy. Though tumor resection is associated with improved seizu... | Recovered | ReactionOutcome | CC BY-NC-ND | 34622193 | 20,432,289 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dermatitis'. | Small cell transformation of non-small cell lung cancer under immunotherapy: Case series and literature review.
In advanced lung cancer treatment, immunotherapy provides durable responses in some patients. However, other patients experience progressive disease and the resistance mechanisms to immunotherapy have yet bee... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34622569 | 19,995,213 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Small cell transformation of non-small cell lung cancer under immunotherapy: Case series and literature review.
In advanced lung cancer treatment, immunotherapy provides durable responses in some patients. However, other patients experience progressive disease and the resistance mechanisms to immunotherapy have yet bee... | CARBOPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY | 34622569 | 20,191,736 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Small cell transformation of non-small cell lung cancer under immunotherapy: Case series and literature review.
In advanced lung cancer treatment, immunotherapy provides durable responses in some patients. However, other patients experience progressive disease and the resistance mechanisms to immunotherapy have yet bee... | CARBOPLATIN, NIVOLUMAB, PACLITAXEL | DrugsGivenReaction | CC BY | 34622569 | 20,352,668 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product use issue'. | Small cell transformation of non-small cell lung cancer under immunotherapy: Case series and literature review.
In advanced lung cancer treatment, immunotherapy provides durable responses in some patients. However, other patients experience progressive disease and the resistance mechanisms to immunotherapy have yet bee... | ATEZOLIZUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY | 34622569 | 19,995,690 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Interstitial lung disease'. | Small cell transformation of non-small cell lung cancer under immunotherapy: Case series and literature review.
In advanced lung cancer treatment, immunotherapy provides durable responses in some patients. However, other patients experience progressive disease and the resistance mechanisms to immunotherapy have yet bee... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34622569 | 19,994,407 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Small cell transformation of non-small cell lung cancer under immunotherapy: Case series and literature review.
In advanced lung cancer treatment, immunotherapy provides durable responses in some patients. However, other patients experience progressive disease and the resistance mechanisms to immunotherapy have yet bee... | BEVACIZUMAB, DOCETAXEL | DrugsGivenReaction | CC BY | 34622569 | 20,321,304 | 2021-11 |
What was the dosage of drug 'ATEZOLIZUMAB'? | Small cell transformation of non-small cell lung cancer under immunotherapy: Case series and literature review.
In advanced lung cancer treatment, immunotherapy provides durable responses in some patients. However, other patients experience progressive disease and the resistance mechanisms to immunotherapy have yet bee... | 8 CYCLE | DrugDosageText | CC BY | 34622569 | 19,973,787 | 2021-11 |
What was the dosage of drug 'CARBOPLATIN'? | Small cell transformation of non-small cell lung cancer under immunotherapy: Case series and literature review.
In advanced lung cancer treatment, immunotherapy provides durable responses in some patients. However, other patients experience progressive disease and the resistance mechanisms to immunotherapy have yet bee... | UNK (FOUR CYCLES) | DrugDosageText | CC BY | 34622569 | 20,325,616 | 2021-11 |
What was the dosage of drug 'DOCETAXEL'? | Small cell transformation of non-small cell lung cancer under immunotherapy: Case series and literature review.
In advanced lung cancer treatment, immunotherapy provides durable responses in some patients. However, other patients experience progressive disease and the resistance mechanisms to immunotherapy have yet bee... | UNK (FOUR CYCLES) | DrugDosageText | CC BY | 34622569 | 20,325,616 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Accidental overdose'. | Iatrogenic topiramate poisoning in an ICU patient: Focus on topiramate peak time prolongation.
A 35-year-old man with generalized insults was admitted to the intensive care unit because of third-line treatment of persistent epileptic insults with antiepileptic drug therapy. Topiramate was added on top of his outpatient... | LACOSAMIDE, LEVETIRACETAM, TOPIRAMATE | DrugsGivenReaction | CC BY | 34622772 | 20,126,029 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Medication error'. | Iatrogenic topiramate poisoning in an ICU patient: Focus on topiramate peak time prolongation.
A 35-year-old man with generalized insults was admitted to the intensive care unit because of third-line treatment of persistent epileptic insults with antiepileptic drug therapy. Topiramate was added on top of his outpatient... | LACOSAMIDE, LEVETIRACETAM, TOPIRAMATE | DrugsGivenReaction | CC BY | 34622772 | 20,126,029 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Iatrogenic topiramate poisoning in an ICU patient: Focus on topiramate peak time prolongation.
A 35-year-old man with generalized insults was admitted to the intensive care unit because of third-line treatment of persistent epileptic insults with antiepileptic drug therapy. Topiramate was added on top of his outpatient... | LACOSAMIDE, LEVETIRACETAM, TOPIRAMATE | DrugsGivenReaction | CC BY | 34622772 | 20,128,314 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product prescribing error'. | Iatrogenic topiramate poisoning in an ICU patient: Focus on topiramate peak time prolongation.
A 35-year-old man with generalized insults was admitted to the intensive care unit because of third-line treatment of persistent epileptic insults with antiepileptic drug therapy. Topiramate was added on top of his outpatient... | LACOSAMIDE, LEVETIRACETAM, TOPIRAMATE | DrugsGivenReaction | CC BY | 34622772 | 20,128,314 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product prescribing issue'. | Iatrogenic topiramate poisoning in an ICU patient: Focus on topiramate peak time prolongation.
A 35-year-old man with generalized insults was admitted to the intensive care unit because of third-line treatment of persistent epileptic insults with antiepileptic drug therapy. Topiramate was added on top of his outpatient... | TOPIRAMATE | DrugsGivenReaction | CC BY | 34622772 | 20,143,477 | 2021-12 |
What is the weight of the patient? | Iatrogenic topiramate poisoning in an ICU patient: Focus on topiramate peak time prolongation.
A 35-year-old man with generalized insults was admitted to the intensive care unit because of third-line treatment of persistent epileptic insults with antiepileptic drug therapy. Topiramate was added on top of his outpatient... | 124 kg. | Weight | CC BY | 34622772 | 20,128,314 | 2021-12 |
What was the administration route of drug 'LACOSAMIDE'? | Iatrogenic topiramate poisoning in an ICU patient: Focus on topiramate peak time prolongation.
A 35-year-old man with generalized insults was admitted to the intensive care unit because of third-line treatment of persistent epileptic insults with antiepileptic drug therapy. Topiramate was added on top of his outpatient... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34622772 | 20,128,314 | 2021-12 |
What was the administration route of drug 'LEVETIRACETAM'? | Iatrogenic topiramate poisoning in an ICU patient: Focus on topiramate peak time prolongation.
A 35-year-old man with generalized insults was admitted to the intensive care unit because of third-line treatment of persistent epileptic insults with antiepileptic drug therapy. Topiramate was added on top of his outpatient... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34622772 | 20,128,314 | 2021-12 |
What was the administration route of drug 'TOPIRAMATE'? | Iatrogenic topiramate poisoning in an ICU patient: Focus on topiramate peak time prolongation.
A 35-year-old man with generalized insults was admitted to the intensive care unit because of third-line treatment of persistent epileptic insults with antiepileptic drug therapy. Topiramate was added on top of his outpatient... | Nasal | DrugAdministrationRoute | CC BY | 34622772 | 20,126,029 | 2021-12 |
What was the outcome of reaction 'Accidental overdose'? | Iatrogenic topiramate poisoning in an ICU patient: Focus on topiramate peak time prolongation.
A 35-year-old man with generalized insults was admitted to the intensive care unit because of third-line treatment of persistent epileptic insults with antiepileptic drug therapy. Topiramate was added on top of his outpatient... | Recovered | ReactionOutcome | CC BY | 34622772 | 20,126,029 | 2021-12 |
What was the outcome of reaction 'Medication error'? | Iatrogenic topiramate poisoning in an ICU patient: Focus on topiramate peak time prolongation.
A 35-year-old man with generalized insults was admitted to the intensive care unit because of third-line treatment of persistent epileptic insults with antiepileptic drug therapy. Topiramate was added on top of his outpatient... | Recovered | ReactionOutcome | CC BY | 34622772 | 20,126,029 | 2021-12 |
What was the outcome of reaction 'Overdose'? | Iatrogenic topiramate poisoning in an ICU patient: Focus on topiramate peak time prolongation.
A 35-year-old man with generalized insults was admitted to the intensive care unit because of third-line treatment of persistent epileptic insults with antiepileptic drug therapy. Topiramate was added on top of his outpatient... | Recovered | ReactionOutcome | CC BY | 34622772 | 20,128,314 | 2021-12 |
What was the outcome of reaction 'Product prescribing error'? | Iatrogenic topiramate poisoning in an ICU patient: Focus on topiramate peak time prolongation.
A 35-year-old man with generalized insults was admitted to the intensive care unit because of third-line treatment of persistent epileptic insults with antiepileptic drug therapy. Topiramate was added on top of his outpatient... | Recovered | ReactionOutcome | CC BY | 34622772 | 20,128,314 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bronchopulmonary aspergillosis'. | Rectal mixed adenoneuroendocrine carcinoma: Case report.
BACKGROUND
Colorectal mixed neuroendocrine-nonneuroendocrine neoplasms constitute a rare group of gastrointestinal tumors composed by both neuroendocrine and nonneuroendocrine components. Nondiagnostic macroscopic features, specific histological features, and poo... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY | 34622834 | 20,307,284 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Rectal mixed adenoneuroendocrine carcinoma: Case report.
BACKGROUND
Colorectal mixed neuroendocrine-nonneuroendocrine neoplasms constitute a rare group of gastrointestinal tumors composed by both neuroendocrine and nonneuroendocrine components. Nondiagnostic macroscopic features, specific histological features, and poo... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY | 34622834 | 20,289,214 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immunosuppression'. | Rectal mixed adenoneuroendocrine carcinoma: Case report.
BACKGROUND
Colorectal mixed neuroendocrine-nonneuroendocrine neoplasms constitute a rare group of gastrointestinal tumors composed by both neuroendocrine and nonneuroendocrine components. Nondiagnostic macroscopic features, specific histological features, and poo... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY | 34622834 | 20,307,284 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | A refractory human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patient with lymphoma-type adult T-cell leukemia/lymphoma: A case report and review of the literature.
BACKGROUND
Adult T-cell leukemia/lymphoma (ATL) and human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/... | CYCLOPHOSPHAMIDE, DOXORUBICIN, HYDROCORTISONE, METHOTREXATE, METHYLPREDNISOLONE, MOGAMULIZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY | 34622865 | 20,128,909 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A refractory human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patient with lymphoma-type adult T-cell leukemia/lymphoma: A case report and review of the literature.
BACKGROUND
Adult T-cell leukemia/lymphoma (ATL) and human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/... | CYCLOPHOSPHAMIDE, DOXORUBICIN, HYDROCORTISONE, METHOTREXATE, METHYLPREDNISOLONE, MOGAMULIZUMAB, PREDNISOLONE | DrugsGivenReaction | CC BY | 34622865 | 20,128,909 | 2021-10-08 |
What was the administration route of drug 'METHOTREXATE'? | A refractory human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patient with lymphoma-type adult T-cell leukemia/lymphoma: A case report and review of the literature.
BACKGROUND
Adult T-cell leukemia/lymphoma (ATL) and human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/... | Intrathecal | DrugAdministrationRoute | CC BY | 34622865 | 20,128,909 | 2021-10-08 |
What was the administration route of drug 'PREDNISOLONE'? | A refractory human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patient with lymphoma-type adult T-cell leukemia/lymphoma: A case report and review of the literature.
BACKGROUND
Adult T-cell leukemia/lymphoma (ATL) and human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/... | Oral | DrugAdministrationRoute | CC BY | 34622865 | 20,128,909 | 2021-10-08 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | A refractory human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patient with lymphoma-type adult T-cell leukemia/lymphoma: A case report and review of the literature.
BACKGROUND
Adult T-cell leukemia/lymphoma (ATL) and human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/... | UNKNOWN, TWO COURSES | DrugDosageText | CC BY | 34622865 | 20,128,909 | 2021-10-08 |
What was the dosage of drug 'DOXORUBICIN'? | A refractory human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patient with lymphoma-type adult T-cell leukemia/lymphoma: A case report and review of the literature.
BACKGROUND
Adult T-cell leukemia/lymphoma (ATL) and human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/... | UNKNOWN, TWO COURSES | DrugDosageText | CC BY | 34622865 | 20,128,909 | 2021-10-08 |
What was the dosage of drug 'MOGAMULIZUMAB'? | A refractory human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patient with lymphoma-type adult T-cell leukemia/lymphoma: A case report and review of the literature.
BACKGROUND
Adult T-cell leukemia/lymphoma (ATL) and human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/... | UNK,EIGHT COURSES | DrugDosageText | CC BY | 34622865 | 20,128,909 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood aldosterone decreased'. | Pancreatic neuroendocrine tumor producing vasopressin: A case report.
BACKGROUND
Functional pancreatic neuroendocrine tumors (pNETs) rarely produce vasopressin. Here, we reported a case of pNET producing vasopressin in a 78-year-old man with hyponatremia.
The patient presented with anorexia approximately 4 years ago, a... | DICLOFENAC SODIUM | DrugsGivenReaction | CC BY | 34622867 | 20,081,163 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Pancreatic neuroendocrine tumor producing vasopressin: A case report.
BACKGROUND
Functional pancreatic neuroendocrine tumors (pNETs) rarely produce vasopressin. Here, we reported a case of pNET producing vasopressin in a 78-year-old man with hyponatremia.
The patient presented with anorexia approximately 4 years ago, a... | DICLOFENAC SODIUM | DrugsGivenReaction | CC BY | 34622867 | 20,081,163 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Pancreatic neuroendocrine tumor producing vasopressin: A case report.
BACKGROUND
Functional pancreatic neuroendocrine tumors (pNETs) rarely produce vasopressin. Here, we reported a case of pNET producing vasopressin in a 78-year-old man with hyponatremia.
The patient presented with anorexia approximately 4 years ago, a... | DICLOFENAC SODIUM | DrugsGivenReaction | CC BY | 34622867 | 20,081,163 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyponatraemia'. | Pancreatic neuroendocrine tumor producing vasopressin: A case report.
BACKGROUND
Functional pancreatic neuroendocrine tumors (pNETs) rarely produce vasopressin. Here, we reported a case of pNET producing vasopressin in a 78-year-old man with hyponatremia.
The patient presented with anorexia approximately 4 years ago, a... | DICLOFENAC SODIUM | DrugsGivenReaction | CC BY | 34622867 | 20,081,163 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypopituitarism'. | Pancreatic neuroendocrine tumor producing vasopressin: A case report.
BACKGROUND
Functional pancreatic neuroendocrine tumors (pNETs) rarely produce vasopressin. Here, we reported a case of pNET producing vasopressin in a 78-year-old man with hyponatremia.
The patient presented with anorexia approximately 4 years ago, a... | DICLOFENAC SODIUM | DrugsGivenReaction | CC BY | 34622867 | 20,081,163 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancreatic neuroendocrine tumour'. | Pancreatic neuroendocrine tumor producing vasopressin: A case report.
BACKGROUND
Functional pancreatic neuroendocrine tumors (pNETs) rarely produce vasopressin. Here, we reported a case of pNET producing vasopressin in a 78-year-old man with hyponatremia.
The patient presented with anorexia approximately 4 years ago, a... | DICLOFENAC SODIUM | DrugsGivenReaction | CC BY | 34622867 | 20,081,163 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renin decreased'. | Pancreatic neuroendocrine tumor producing vasopressin: A case report.
BACKGROUND
Functional pancreatic neuroendocrine tumors (pNETs) rarely produce vasopressin. Here, we reported a case of pNET producing vasopressin in a 78-year-old man with hyponatremia.
The patient presented with anorexia approximately 4 years ago, a... | DICLOFENAC SODIUM | DrugsGivenReaction | CC BY | 34622867 | 20,081,163 | 2021-10-08 |
What was the outcome of reaction 'Hyponatraemia'? | Pancreatic neuroendocrine tumor producing vasopressin: A case report.
BACKGROUND
Functional pancreatic neuroendocrine tumors (pNETs) rarely produce vasopressin. Here, we reported a case of pNET producing vasopressin in a 78-year-old man with hyponatremia.
The patient presented with anorexia approximately 4 years ago, a... | Recovered | ReactionOutcome | CC BY | 34622867 | 20,081,163 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disseminated intravascular coagulation'. | Hemorrhagic disseminated intravascular coagulation after 177Lu-Dotatate in metastatic midgut neuroendocrine tumor: A case report.
BACKGROUND
Peptide receptor radionuclide therapy with 177Lu-Dotatate represents a major breakthrough in the treatment of metastatic well differentiated neuroendocrine tumors. This treatment ... | HYDROCHLOROTHIAZIDE, IRBESARTAN, LERCANIDIPINE, LUTETIUM OXODOTREOTIDE LU-177 | DrugsGivenReaction | CC BY | 34622868 | 20,008,812 | 2021-10-08 |
What was the administration route of drug 'LUTETIUM OXODOTREOTIDE LU-177'? | Hemorrhagic disseminated intravascular coagulation after 177Lu-Dotatate in metastatic midgut neuroendocrine tumor: A case report.
BACKGROUND
Peptide receptor radionuclide therapy with 177Lu-Dotatate represents a major breakthrough in the treatment of metastatic well differentiated neuroendocrine tumors. This treatment ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34622868 | 20,008,812 | 2021-10-08 |
What was the dosage of drug 'LUTETIUM OXODOTREOTIDE LU-177'? | Hemorrhagic disseminated intravascular coagulation after 177Lu-Dotatate in metastatic midgut neuroendocrine tumor: A case report.
BACKGROUND
Peptide receptor radionuclide therapy with 177Lu-Dotatate represents a major breakthrough in the treatment of metastatic well differentiated neuroendocrine tumors. This treatment ... | 7.4 GBQ, UNKNOWN | DrugDosageText | CC BY | 34622868 | 20,008,812 | 2021-10-08 |
What was the outcome of reaction 'Disseminated intravascular coagulation'? | Hemorrhagic disseminated intravascular coagulation after 177Lu-Dotatate in metastatic midgut neuroendocrine tumor: A case report.
BACKGROUND
Peptide receptor radionuclide therapy with 177Lu-Dotatate represents a major breakthrough in the treatment of metastatic well differentiated neuroendocrine tumors. This treatment ... | Recovered | ReactionOutcome | CC BY | 34622868 | 20,008,812 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute hepatic failure'. | Maternal and fetal outcomes of pregnancies complicated by acute hepatitis E and the impact of HIV status: A cross-sectional study in Namibia.
OBJECTIVE
Namibia has been suffering from an outbreak of hepatitis E genotype 2 since 2017. As nearly half of hepatitis E-related deaths were among pregnant and postpartum women,... | ATAZANAVIR\RITONAVIR, LAMIVUDINE\TENOFOVIR, ZIDOVUDINE | DrugsGivenReaction | CC BY-NC-ND | 34623734 | 20,410,007 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Maternal and fetal outcomes of pregnancies complicated by acute hepatitis E and the impact of HIV status: A cross-sectional study in Namibia.
OBJECTIVE
Namibia has been suffering from an outbreak of hepatitis E genotype 2 since 2017. As nearly half of hepatitis E-related deaths were among pregnant and postpartum women,... | ATAZANAVIR\RITONAVIR, LAMIVUDINE\TENOFOVIR, ZIDOVUDINE | DrugsGivenReaction | CC BY-NC-ND | 34623734 | 20,410,007 | 2021-10-08 |
What was the outcome of reaction 'Acute hepatic failure'? | Maternal and fetal outcomes of pregnancies complicated by acute hepatitis E and the impact of HIV status: A cross-sectional study in Namibia.
OBJECTIVE
Namibia has been suffering from an outbreak of hepatitis E genotype 2 since 2017. As nearly half of hepatitis E-related deaths were among pregnant and postpartum women,... | Fatal | ReactionOutcome | CC BY-NC-ND | 34623734 | 20,410,007 | 2021-10-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Small cell transformation in crizotinib-resistant ROS1-rearranged non-small cell lung cancer with retention of ROS1 fusion: A case report.
C-ros oncogene 1 receptor tyrosine kinase (ROS1) rearrangement has been detected in patients with advanced non-small cell lung cancer (NSCLC). Although ROS1 tyrosine kinase inhibito... | CISPLATIN, CRIZOTINIB, ETOPOSIDE, GEMCITABINE, PACLITAXEL, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34623764 | 20,298,860 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Small cell transformation in crizotinib-resistant ROS1-rearranged non-small cell lung cancer with retention of ROS1 fusion: A case report.
C-ros oncogene 1 receptor tyrosine kinase (ROS1) rearrangement has been detected in patients with advanced non-small cell lung cancer (NSCLC). Although ROS1 tyrosine kinase inhibito... | CISPLATIN, CRIZOTINIB, ETOPOSIDE, GEMCITABINE, PACLITAXEL, PEMETREXED | DrugsGivenReaction | CC BY-NC-ND | 34623764 | 20,325,111 | 2021-11 |
What was the dosage of drug 'CISPLATIN'? | Small cell transformation in crizotinib-resistant ROS1-rearranged non-small cell lung cancer with retention of ROS1 fusion: A case report.
C-ros oncogene 1 receptor tyrosine kinase (ROS1) rearrangement has been detected in patients with advanced non-small cell lung cancer (NSCLC). Although ROS1 tyrosine kinase inhibito... | FURTHER CHEMOTHERAPY WITH ETOPOSIDE | DrugDosageText | CC BY-NC-ND | 34623764 | 20,298,860 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Autoimmune hepatitis'. | Inflammatory complications of CGRP monoclonal antibodies: a case series.
BACKGROUND
Calcitonin gene-related peptide (CGRP) is expressed throughout the body and is a known mediator of migraine, exerting this biological effect through activation of trigeminovascular, meningeal and associated neuronal pathways located in ... | ATENOLOL, ERENUMAB, FENOFIBRATE, ROSUVASTATIN | DrugsGivenReaction | CC BY | 34625019 | 19,976,055 | 2021-10-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Concomitant disease aggravated'. | Inflammatory complications of CGRP monoclonal antibodies: a case series.
BACKGROUND
Calcitonin gene-related peptide (CGRP) is expressed throughout the body and is a known mediator of migraine, exerting this biological effect through activation of trigeminovascular, meningeal and associated neuronal pathways located in ... | ADALIMUMAB, AMITRIPTYLINE, ERENUMAB, FENOFIBRATE, GABAPENTIN, NARATRIPTAN HYDROCHLORIDE, PANTOPRAZOLE, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34625019 | 19,971,612 | 2021-10-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Deafness unilateral'. | Inflammatory complications of CGRP monoclonal antibodies: a case series.
BACKGROUND
Calcitonin gene-related peptide (CGRP) is expressed throughout the body and is a known mediator of migraine, exerting this biological effect through activation of trigeminovascular, meningeal and associated neuronal pathways located in ... | ERENUMAB, FREMANEZUMAB | DrugsGivenReaction | CC BY | 34625019 | 20,087,942 | 2021-10-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug reaction with eosinophilia and systemic symptoms'. | Inflammatory complications of CGRP monoclonal antibodies: a case series.
BACKGROUND
Calcitonin gene-related peptide (CGRP) is expressed throughout the body and is a known mediator of migraine, exerting this biological effect through activation of trigeminovascular, meningeal and associated neuronal pathways located in ... | ERENUMAB, ZOLMITRIPTAN | DrugsGivenReaction | CC BY | 34625019 | 19,972,903 | 2021-10-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paranasal sinus discomfort'. | Inflammatory complications of CGRP monoclonal antibodies: a case series.
BACKGROUND
Calcitonin gene-related peptide (CGRP) is expressed throughout the body and is a known mediator of migraine, exerting this biological effect through activation of trigeminovascular, meningeal and associated neuronal pathways located in ... | ERENUMAB, FREMANEZUMAB | DrugsGivenReaction | CC BY | 34625019 | 20,087,942 | 2021-10-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Psoriatic arthropathy'. | Inflammatory complications of CGRP monoclonal antibodies: a case series.
BACKGROUND
Calcitonin gene-related peptide (CGRP) is expressed throughout the body and is a known mediator of migraine, exerting this biological effect through activation of trigeminovascular, meningeal and associated neuronal pathways located in ... | ADALIMUMAB, AMITRIPTYLINE, ERENUMAB, FENOFIBRATE, GABAPENTIN, NARATRIPTAN HYDROCHLORIDE, PANTOPRAZOLE, VERAPAMIL HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34625019 | 19,971,612 | 2021-10-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Susac^s syndrome'. | Inflammatory complications of CGRP monoclonal antibodies: a case series.
BACKGROUND
Calcitonin gene-related peptide (CGRP) is expressed throughout the body and is a known mediator of migraine, exerting this biological effect through activation of trigeminovascular, meningeal and associated neuronal pathways located in ... | CANDESARTAN, CLOMIPRAMINE, ERENUMAB, ESOMEPRAZOLE, NARATRIPTAN HYDROCHLORIDE, PREGABALIN | DrugsGivenReaction | CC BY | 34625019 | 19,967,442 | 2021-10-09 |
What was the outcome of reaction 'Autoimmune hepatitis'? | Inflammatory complications of CGRP monoclonal antibodies: a case series.
BACKGROUND
Calcitonin gene-related peptide (CGRP) is expressed throughout the body and is a known mediator of migraine, exerting this biological effect through activation of trigeminovascular, meningeal and associated neuronal pathways located in ... | Recovering | ReactionOutcome | CC BY | 34625019 | 19,976,055 | 2021-10-09 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.